VIRUS RESEARCH INSTITUTE INC (CIK: 0000902010) EDGAR, Information, Filings... CompaniesBIO.Com

VIRUS RESEARCH INSTITUTE INC

Mailing address
61 MOULTON ST, CAMBRIDGE, Delaware, 02138
Phone
6178646232
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

VIRUS RESEARCH INSTITUTE INC (CIK: 0000902010) is an American company incorporated in the state of Massachusetts. Head office is located at 61 MOULTON ST, CAMBRIDGE, Massachusetts, 02139. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). VIRUS RESEARCH INSTITUTE INC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by VIRUS RESEARCH INSTITUTE INC

Filings	Format	Description	Filed/Effective	File/Film Number
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001029869-98-001063 ( Act) Size: KB	Aug-21-1998	000-20711 98695684
RW	Document	Registration Withdrawal Request Acc-no: 0001029869-98-001062 ( Act) Size: KB	Aug-21-1998	333-13245 98695498
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950135-98-004742 ( Act) Size: KB	Aug-14-1998	000-20711 98687538
DEFM14A	Document	Definitive proxy statement relating to a merger,acquisition, or disposition Acc-no: 0001029869-98-000947 ( Act) Size: KB	Jul-20-1998	000-20711 98668884
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001047469-98-023162 ( Act) Size: KB	Jun-05-1998	005-49497 98643423
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001029869-98-000713 ( Act) Size: KB	May-21-1998	005-49497 98629932
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950135-98-003191 ( Act) Size: KB	May-13-1998	000-20711 98618156
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001047469-98-018933 ( Act) Size: KB	May-08-1998	005-49497 98614401
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001047469-98-018932 ( Act) Size: KB	May-08-1998	005-49497 98614384
DEF 14A	Document	Definitive proxy statements Acc-no: 0000950135-98-002248 ( Act) Size: KB	Apr-07-1998	000-20711 98588594
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0000950135-98-002010 ( Act) Size: KB	Mar-30-1998	000-20711 98578541
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950116-98-000338 ( Act) Size: KB	Feb-13-1998	005-49497 98539178
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950162-98-000041 ( Act) Size: KB	Jan-12-1998	005-49497 98504613
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000898430-97-005433 ( Act) Size: KB	Dec-24-1997	005-49497 97743771
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950135-97-004582 ( Act) Size: KB	Nov-14-1997	000-20711 97718414
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950162-97-000568 ( Act) Size: KB	Aug-13-1997	005-49497 97658006
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950135-97-003226 ( Act) Size: KB	Aug-05-1997	000-20711 97651271
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950162-97-000461 ( Act) Size: KB	Jun-20-1997	005-49497 97627367
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950135-97-002222 ( Act) Size: KB	May-08-1997	000-20711 97598003
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950162-97-000312 ( Act) Size: KB	Apr-04-1997	005-49497 97574878

Recent 20 filings. View all VIRUS RESEARCH INSTITUTE INC filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

VIRUS RESEARCH INSTITUTE INC overview
VIRUS RESEARCH INSTITUTE INC job
VIRUS RESEARCH INSTITUTE INC stock
VIRUS RESEARCH INSTITUTE INC ownership
VIRUS RESEARCH INSTITUTE INC CEO
VIRUS RESEARCH INSTITUTE INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.